Bio-Rad Laboratories
As on 02 Jul, 2025 | 01:29 IST
| Open | 241.43 |
| Previous Close | 241.65 |
| Beta | 0.78 |
| High | 254.82 |
| Low | 238.90 |
| TTM EPS See historical trend | 10.56(-1.49% YoY) |
| 52 Week High | 387.99 |
| 52 Week Low | 211.69 |
| TTM PE See historical trend | 23.50(Average PE) |
| Mkt. Cap ($ Billion) | 5.69 |
| Dividend Yield | -- |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 243.85 |
| 10 | 239.19 |
| 20 | 232.67 |
| 50 | 236.17 |
| 100 | 251.21 |
| 200 | 295.31 |
Returns
| 1 Week | -4.50% | |
| 1 Month | 7.65% | |
| 3 Months | 4.27% | |
| YTD | -24.56% | |
| 1 Year | -22.16% | |
| 3 Years | -49.76% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| General Electric Aerospace | 304.64 | 0.17 | 328.70 | 47.60 | 6.38 | 0.47 | 348.48/176.34 | 6.03 | Very Bullish |
| Merck | 117.10 | -1.65 | 296.60 | 13.06 | 8.97 | 3.12 | 125.14/73.35 | 2.58 | Bearish |
| Thermo Fisher Scientific | 526.02 | -0.11 | 200.70 | 23.01 | 22.87 | 0.30 | 643.99/385.72 | 10.89 | Very Bullish |
| Abbott | 96.00 | -0.84 | 166.53 | 18.43 | 5.21 | 2.38 | 139.02/93.95 | -9.05 | Very Bearish |
| Danaher | 195.78 | 0.53 | 141.21 | 25.07 | 7.80 | 0.56 | 242.75/180.09 | 3.17 | Neutral |
Market news
- Wall St ends mixed, notches weekly gains as investors parse Middle East negotiationsApril 11, 2026 8:53 AM
- Wall Street skids as Middle East turmoil fans inflation fearMarch 21, 2026 9:02 AM
- Wall Street closes lower, posts weekly loss as war on Iran fuels inflation worriesMarch 14, 2026 8:59 AM
- US stocks close down as oil spikes 12%, job market weakensMarch 7, 2026 9:27 AM
About the company
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.